Didier Dargent

Didier Dargent is a seasoned executive with extensive experience in the healthcare sector, currently serving as the CEO and Board Member of Cube Biotech since March 2023. Dargent has held significant roles at prominent organizations, including as an Operating Partner at ArchiMed, Board Observer at PlasmidFactory GmbH, and Board Member at Title21 Health Solutions. Previously, Dargent excelled in leadership positions at Novartis Oncology, where responsibilities included advancing Cell & Gene Therapy initiatives across multiple regions, and at Servier, where management of substantial turnover and staff resulted in significant market growth and organizational improvements. Educational qualifications include dual Executive MBAs from INSEAD and Tsinghua University, an MSc in Pharmaceutical and Biotechnology Management from ESCP Business School, and a PhD in Pharmacy from Aix-Marseille University.